EUVIMEDEUVIMED entdecken
Crossref

Multimodel RBE and Dose-Averaged LET Optimized Carbon Ion Radiation Therapy for Sacral Chordoma: Results of the First Year of Clinical Application

Silvia Molinelli, Alessia Bazani, Giuseppe Magro, Marco Rotondi, Stefania Russo, Agnieszka Chalaszczyk, Elettra Dorotea Ferrari, Mario Ciocca, Ester Orlandi, Maria Rosaria Fiore

International Journal of Radiation Oncology*Biology*Physics · 2026

DOI: 10.1016/j.ijrobp.2026.07.062 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Radiation Oncology*Biology*Physics, 2026. Verfasst von Silvia Molinelli und 9 weiteren Autor:innen. Beteiligte Einrichtung: Radiation Oncology Unit, CNAO National Center for Oncological Hadrontherapy, Pavia, Italy. Electronic address: silvia.molinelli@cnao.it. Hauptthemen laut MEDLINE: Chordoma, Relative Biological Effectiveness, Sacrum, Spinal Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 31 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: Carbon ion therapy (CIRT) optimization, driven by purely dosimetric and single-relative biological effectiveness (RBE) model may result in suboptimal solutions, particularly when considering dose-averaged LET (LETd) within the tumor. This study reports on the early outcomes of a clinical optimization strategy combining compliance with multi-RBE and explicit LETd escalation in a cohort of 10 patients with sacral chordoma treated with CIRT. METHODS AND MATERIALS: Treatment plans, optimized with dosimetric objectives to a prescribed RBE-weighted dose (DRBE) of 73.6 Gy(RBE), using the local effect model (LEM) (Plan-D), served as the benchmark. The proposed strategy consisted of 3 steps: (1) plan optimization using the microdosimetric kinetic model (MKM) to 67.2 Gy(RBE); (2) iterative LEM-based recalculation to obtain plans compliant with RBE models; (3) inclusion of a cost-function term on the minimum LETd (LETd-min) to the gross tumor volume (GTV) (plan-L). The selected LETd-min ensured compliance with clinical goals under both nominal and robust scenarios. Plan-D and Plan-L were compared using variations in DRBE, LEM and MKM, and LETd to target volume percentages. Re-evaluation computed tomographies assessed interfraction robustness. Paired comparisons used the Wilcoxon signed-rank test. Acute toxicity was evaluated during treatment and at early follow-up. RESULTS: The median GTV volume was 171.1 cc (90.6-636.7). The median LETd-min constraint applied was 44 keV/μm (range, 40-48). The median GTV LETd-98% increase was 29.2%, from 32.9 keV/μm (Plan-D) to 42.5 keV/μm (Plan-L). LEM-based dose deviations were not clinically relevant, while Plan-L showed significantly improved MKM dose homogeneity compared with Plan-D. Interfraction robustness of target coverage was comparable for both dose and LETd metrics, with deviations below 2% relative to the nominal plan. The early toxicity profile was clinically acceptable. CONCLUSIONS: This study supports the feasibility of a novel optimization strategy for CIRT in large sacral chordomas, based on the synergistic maximization of dose, RBE, and LETd within the target, with acceptable robustness and well-tolerated acute toxicity in this initial patient series.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ChordomaRelative Biological EffectivenessSacrumSpinal NeoplasmsHeavy Ion RadiotherapyLinear Energy TransferRadiotherapy Planning, Computer-AssistedHumansRadiotherapy DosageTumor BurdenFemaleAgedMiddle AgedMale

Autor:innen und Institutionen

  • Radiation Oncology Unit, CNAO National Center for Oncological Hadrontherapy, Pavia, Italy. Electronic address: silvia.molinelli@cnao.it.
  • Radiation Oncology Unit, CNAO National Center for Oncological Hadrontherapy, Pavia, Italy.
  • Department of Clinical, Surgical, Diagnostic, and Pediatric Sciences, University of Pavia, Pavia, Italy; Radiation Oncology Unit, CNAO National Center for Oncological Hadrontherapy, Pavia, Italy.

Zitieren

APA

Molinelli, S., Bazani, A., Magro, G., Rotondi, M., Russo, S., Chalaszczyk, A., Ferrari, E. D., Ciocca, M., Orlandi, E., & Fiore, M. R. (2026). Multimodel RBE and Dose-Averaged LET Optimized Carbon Ion Radiation Therapy for Sacral Chordoma: Results of the First Year of Clinical Application. International Journal of Radiation Oncology*Biology*Physics. https://doi.org/10.1016/j.ijrobp.2026.07.062

Vancouver

Molinelli S, Bazani A, Magro G, Rotondi M, Russo S, Chalaszczyk A, et al. Multimodel RBE and Dose-Averaged LET Optimized Carbon Ion Radiation Therapy for Sacral Chordoma: Results of the First Year of Clinical Application. International Journal of Radiation Oncology*Biology*Physics. 2026. doi:10.1016/j.ijrobp.2026.07.062

BibTeX
@article{Molinelli2026,
  author = {Molinelli, Silvia and Bazani, Alessia and Magro, Giuseppe and Rotondi, Marco and Russo, Stefania and Chalaszczyk, Agnieszka and Ferrari, Elettra Dorotea and Ciocca, Mario and Orlandi, Ester and Fiore, Maria Rosaria},
  title = {Multimodel RBE and Dose-Averaged LET Optimized Carbon Ion Radiation Therapy for Sacral Chordoma: Results of the First Year of Clinical Application},
  journal = {International Journal of Radiation Oncology*Biology*Physics},
  year = {2026},
  doi = {10.1016/j.ijrobp.2026.07.062}
}
Kostenlos starten →